- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.05. | Prenetics Global Limited: Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | 6 | GlobeNewswire (USA) | ||
| 14.05. | Prenetics Global Reports Q1 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 14.05. | Prenetics raises 2026 guidance on IM8 supplement growth | 2 | Investing.com | ||
| 14.05. | Prenetics Global reports Q1 results; gives Q2 and raises FY26 outlook | 3 | Seeking Alpha | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 14.05. | Prenetics Global Limited: Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 | 346 | GlobeNewswire (Europe) | ~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support its rapid global expansion NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 14.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.05. | Prenetics Global Limited: Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 04.05. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.04. | Prenetics Global Limited: Prenetics' IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One | 5 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics gewinnt NBA-Star Giannis Antetokounmpo als neuen Aktionär und Partner | 5 | Investing.com Deutsch | ||
| 02.04. | Prenetics Global Limited: Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership | 2 | GlobeNewswire (USA) | ||
| 02.04. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 01.04. | Prenetics Global (PRE) Partners with Superpower on Diagnostics and Supplements | 5 | Insider Monkey | ||
| 24.03. | Prenetics Global Limited: Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation | 3 | GlobeNewswire (USA) | ||
| 06.03. | Prenetics: Aktienrückkaufprogramm über 40 Mio. USD treibt Kurs an | 2 | Investing.com Deutsch | ||
| 06.03. | Prenetics Global Board Authorizes Share Repurchase Program | - | RTTNews | ||
| 06.03. | Prenetics rises on $40M share buyback program | 1 | Seeking Alpha | ||
| 06.03. | Prenetics announces $40M share buyback program | 1 | Investing.com | ||
| 06.03. | Prenetics Global Limited: Prenetics Authorizes $40 Million Share Repurchase Program | 1 | GlobeNewswire (USA) | ||
| 03.03. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 536,20 | +0,47 % | CytomX Therapeutics Inc.: CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer | - Expanded collaboration builds upon research momentum in developing next-generation bispecific immunotherapies using CytomX's PROBODY- and Regeneron's Veloci-Bi- platforms - - CytomX to receive... ► Artikel lesen | |
| VIKING THERAPEUTICS | 25,400 | +0,40 % | Bull vs. Bear: The Quick Take on Viking Therapeutics Stock | ||
| CANSINO BIOLOGICS | 2,700 | -6,25 % | CanSino Biologics Inc: CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion | HONG KONG, Apr 28, 2026 - (ACN Newswire) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled... ► Artikel lesen | |
| GUARDANT HEALTH | 111,00 | +1,33 % | Stifel reiterates Guardant Health stock rating on screening outlook | ||
| SINO BIOPHARM | 0,530 | +2,22 % | SBP GROUP Innovative Drug TQB3616 Combination Regimen Achieves Pre-set Primary Endpoint | ||
| BIO-TECHNE | 43,230 | -1,39 % | BIO-TECHNE: Zarter Anlauf. | Der Biotech-Laborausrüster aus Minneapolis hatte allein seit Januar weitere 39 % an Kurswert abgegeben. Gegenüber dem Allzeithoch vom Oktober 2021 gilt die Kursdrittelung; allerdings stand die damalige... ► Artikel lesen | |
| GENSCRIPT BIOTECH | 1,430 | 0,00 % | GENSCRIPT BIO Surges 19% as Legend Biotech Corporation Announces Positive Preliminary Clinical Data for Lymphoma Therapy | ||
| INNOVENT BIOLOGICS | 8,769 | +3,06 % | Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines | SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the... ► Artikel lesen | |
| QUANTUM-SI | 1,180 | -0,84 % | Quantum-Si Incorporated: Quantum-Si Announces the Start of the Proteus Roadshow | Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics... ► Artikel lesen | |
| SCILEX | 6,250 | +0,81 % | Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026 | PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,925 | +1,09 % | Origin Agritech Limited: Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026 | Net Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating Expenses
BEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)... ► Artikel lesen | |
| AKESO | 11,100 | 0,00 % | BofAS Raises AKESO TP to HKD164, Reiterates Buy Rating | ||
| HARMONY BIOSCIENCES | 32,110 | +0,03 % | H.C. Wainwright reiterates Harmony Biosciences stock rating at buy | ||
| MINERALYS THERAPEUTICS | 25,050 | -0,04 % | Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing | - Repurchase of lorundrostat royalty obligation in Tanabe license agreement for $200 million upfront and up to $100 million once certain commercial milestones are met - - $500 million committed... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 278,89 | -0,01 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Vormatrigine Program Update | POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary success measure Secondary measure, the 50% response rate, was met and seizure reduction during the second... ► Artikel lesen |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,140 (+0,67 %) liegt der Kurs bei 20,970 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.